Enterohemorrhagic Escherichia coli O26:H11-associated hemolytic uremic syndrome: Bacteriology and clinical presentation

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 6, 2010, Pages 586-593

  Zimmerhackl, Lothar Bernd ^a   Rosales, Alejandra ^a   Hofer, Johannes ^a   Riedl, Magdalena ^a   Jungraithmayr, Therese ^a   Mellmann, Alexander ^b   Bielaszewska, Martina ^b   Karch, Helge ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

EHEC; HUS; long term outcome; morbidity; O26

Indexed keywords

ARTICLE; BACTERIOLOGY; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ENTEROHEMORRHAGIC ESCHERICHIA COLI; HEMOLYTIC UREMIC SYNDROME; HUMAN; MORBIDITY; POPULATION GENETICS; PRIORITY JOURNAL; SEROTYPE;

AUSTRIA; CHILD; CHILD, PRESCHOOL; DIARRHEA; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FEMALE; GERMANY; HEMOLYTIC-UREMIC SYNDROME; HOST-PATHOGEN INTERACTIONS; HUMANS; HYPERTENSION; INFANT; LEUKOCYTE COUNT; MALE; PERITONEAL DIALYSIS; PHYLOGENY; PLATELET COUNT; PROSPECTIVE STUDIES; RENAL DIALYSIS; SHIGA TOXIN 2; SPECIES SPECIFICITY; VIRULENCE;

EID: 77957591285     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1262880     Document Type: Article

References (61)

1. Siegler R L. The hemolytic uremic syndrome. Pediatr Clin North Am 1995 42 (6) 1505-1529
2. Karmali M A., Steele B T., Petric M, Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1983 1 (8325) 619-620
3. Levine M M., Xu J G., Kaper J B. et al. A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis 1987 156 (1) 175-182
4. Chandler W L., Jelacic S, Boster D R. et al. Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N Engl J Med 2002 346 (1) 23-32
5. Bell B P., Goldoft M, Griffin P M. et al. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA 1994 272 (17) 1349-1353
6. Brandt J, Wong C, Mihm S et al. Invasive pneumococcal disease and hemolytic uremic syndrome. Pediatrics 2002 110 (2 Pt 1) 371-376
7. Loirat C, Noris M, Frémeaux-Bacchi V. Complement and the atypical hemolytic uremic syndrome in children. Pediatr Nephrol 2008 23 (11) 1957-1972
8. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009 361 (17) 1676-1687
9. Zimmerhackl L B. Epidemiology, pathogenesis and therapeutic modalities in hemolytic-uremic syndrome. Kidney Blood Press Res 1998 21 (24) 290-292
10. Banatvala N, Griffin P M., Greene K D. et al, Hemolytic Uremic Syndrome Study Collaborators. The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 2001 183 (7) 1063-1070
11. Ethelberg S, Smith B, Torpdahl M et al. Outbreak of non-O157 Shiga toxin-producing Escherichia coli infection from consumption of beef sausage. Clin Infect Dis 2009 48 (8) e78-e81
12. Werber D, Behnke S C., Fruth A et al. Shiga toxin-producing Escherichia coli infection in Germany: different risk factors for different age groups. Am J Epidemiol 2007 165 (4) 425-434
13. Banatvala N, Debeukelaer M M., Griffin P M. et al. Shiga-like toxin-producing Escherichia coli O111 and associated hemolytic-uremic syndrome: a family outbreak. Pediatr Infect Dis J 1996 15 (11) 1008-1011
14. Brooks J T., Bergmire-Sweat D, Kennedy M et al. Outbreak of Shiga toxin-producing Escherichia coli O111:H8 infections among attendees of a high school cheerleading camp. Clin Infect Dis 2004 38 (2) 190-198
15. Caprioli A, Luzzi I, Rosmini F et al. Community-wide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli. J Infect Dis 1994 169 (1) 208-211
16. Elliott E J., Robins-Browne R M., O'Loughlin E V. et al, Contributors to the Australian Paediatric Surveillance Unit. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child 2001 85 (2) 125-131
17. Fey P D., Wickert R S., Rupp M E., Safranek T J., Hinrichs S H. Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 2000 6 (5) 530-533
18. Werber D, Fruth A, Liesegang A et al. A multistate outbreak of Shiga toxin-producing Escherichia coli O26:H11 infections in Germany, detected by molecular subtyping surveillance. J Infect Dis 2002 186 (3) 419-422
19. Karch H, Tarr P I., Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 2005 295 (6-7) 405-418
20. Jenkins C, Evans J, Chart H, Willshaw G A., Frankel G. Escherichia coli serogroup O26a new look at an old adversary. J Appl Microbiol 2008 104 (1) 14-25
21. Tozzi A E., Caprioli A, Minelli F et al, Hemolytic Uremic Syndrome Study Group. Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 19882000. Emerg Infect Dis 2003 9 (1) 106-108
22. Brooks J T., Sowers E G., Wells J G. et al. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 19832002. J Infect Dis 2005 192 (8) 1422-1429
23. Hedican E B., Medus C, Besser J M. et al. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 20002006. Clin Infect Dis 2009 49 (3) 358-364
24. Jelacic J K., Damrow T, Chen G S. et al. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J Infect Dis 2003 188 (5) 719-729
25. Rivas M, Miliwebsky E, Chinen I et al, Case-Control Study Group. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina. Foodborne Pathog Dis 2006 3 (1) 88-96
26. Rivero M A., Passucci J A., Rodriguez E M., Parma A E. Role and clinical course of verotoxigenic Escherichia coli infections in childhood acute diarrhea in Argentina. J Med Microbiol 2010 59 345-352
27. Hoshina K, Itagaki A, Seki R et al. Enterohemorrhagic Escherichia coli O26 outbreak caused by contaminated natural water supplied by facility owned by local community. Jpn J Infect Dis 2001 54 (6) 247-248
28. Bielaszewska M, Köck R, Friedrich A W. et al. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS One 2007 2 (10) e1024
29. Gerber A, Karch H, Allerberger F, Verweyen H M., Zimmerhackl L B. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 19972000, in Germany and Austria: a prospective study. J Infect Dis 2002 186 (4) 493-500
30. Mellmann A, Bielaszewska M, Köck R et al. Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerg Infect Dis 2008 14 (8) 1287-1290
31. McMaster C, Roch E A., Willshaw G A., Doherty A, Kinnear W, Cheasty T. Verocytotoxin-producing Escherichia coli serotype O26:H11 outbreak in an Irish crèche. Eur J Clin Microbiol Infect Dis 2001 20 (6) 430-432
32. Misselwitz J, Karch H, Bielazewska M et al. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11. Pediatr Infect Dis J 2003 22 (4) 349-354
33. Sonoda C, Tagami A, Nagatomo D et al. An enterohemorrhagic Escherichia coli O26 outbreak at a nursery school in Miyazaki, Japan. Jpn J Infect Dis 2008 61 (1) 92-93
34. Allerberger F, Friedrich A W., Grif K et al. Hemolytic-uremic syndrome associated with enterohemorrhagic Escherichia coli O26:H infection and consumption of unpasteurized cow's milk. Int J Infect Dis 2003 7 (1) 42-45
35. Bielaszewska M, Zhang W, Tarr P I., Sonntag A K., Karch H. Molecular profiling and phenotype analysis of Escherichia coli O26:H11 and O26:NM: secular and geographic consistency of enterohemorrhagic and enteropathogenic isolates. J Clin Microbiol 2005 43 (8) 4225-4228
36. Friedrich A W., Bielaszewska M, Zhang W L. et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 2002 185 (1) 74-84
37. Bitzan M, Moebius E, Ludwig K, Müller-Wiefel D E., Heesemann J, Karch H. High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. J Pediatr 1991 119 (3) 380-385
38. Espié E, Grimont F, Mariani-Kurkdjian P et al. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 19962006. Pediatr Infect Dis J 2008 27 (7) 595-601
39. Caprioli A, Tozzi A E., Rizzoni G, Karch H. Non-O157 Shiga toxin-producing Escherichia coli infections in Europe. Emerg Infect Dis 1997 3 (4) 578-579
40. Loirat C, Sonsino E, Varga Moreno A et al. Hemolytic-uremic syndrome: an analysis of the natural history and prognostic features. Acta Paediatr Scand 1984 73 (4) 505-514
41. Siegler R L., Milligan M K., Burningham T H., Christofferson R D., Chang S Y., Jorde L B. Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome. J Pediatr 1991 118 (2) 195-200
42. Siegler R L., Pavia A T., Christofferson R D., Milligan M K. A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics 1994 94 (1) 35-40
43. Siegler R L., Pavia A T., Hansen F L., Christofferson R D., Cook J B. Atypical hemolytic-uremic syndrome: a comparison with postdiarrheal disease. J Pediatr 1996 128 (4) 505-511
44. Tönshoff B, Sammet A, Sanden I, Mehls O, Waldherr R, Schärer K. Outcome and prognostic determinants in the hemolytic uremic syndrome of children. Nephron 1994 68 (1) 63-70
45. Gianviti A, Tozzi A E., De Petris L et al. Risk factors for poor renal prognosis in children with hemolytic uremic syndrome. Pediatr Nephrol 2003 18 (12) 1229-1235
46. Ogura Y, Ooka T, Iguchi A et al. Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc Natl Acad Sci U S A 2009 106 (42) 17939-17944
47. Mellmann A, Bielaszewska M, Karch H. Intrahost genome alterations in enterohemorrhagic Escherichia coli. Gastroenterology 2009 136 (6) 1925-1938
48. Zhang W, Mellmann A, Sonntag A K. et al. Structural and functional differences between disease-associated genes of enterohaemorrhagic Escherichia coli O111. Int J Med Microbiol 2007 297 (1) 17-26
49. Aldick T, Bielaszewska M, Zhang W et al. Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium. Microbes Infect 2007 9 (3) 282-290
50. Aldick T, Bielaszewska M, Uhlin B E., Humpf H U., Wai S N., Karch H. Vesicular stabilization and activity augmentation of enterohaemorrhagic Escherichia coli haemolysin. Mol Microbiol 2009 71 (6) 1496-1508
51. Brockmeyer J, Bielaszewska M, Fruth A et al. Subtypes of the plasmid-encoded serine protease EspP in Shiga toxin-producing Escherichia coli: distribution, secretion, and proteolytic activity. Appl Environ Microbiol 2007 73 (20) 6351-6359
52. Tarr P I., Bilge S S., Vary J C. Jr et al. Iha: a novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a recently acquired chromosomal island of conserved structure. Infect Immun 2000 68 (3) 1400-1407
53. Toma C, Martnez Espinosa E, Song T et al. Distribution of putative adhesins in different seropathotypes of Shiga toxin-producing Escherichia coli. J Clin Microbiol 2004 42 (11) 4937-4946
54. Bielaszewska M, Sonntag A K., Schmidt M A., Karch H. Presence of virulence and fitness gene modules of enterohemorrhagic Escherichia coli in atypical enteropathogenic Escherichia coli O26. Microbes Infect 2007 9 (7) 891-897
55. Karch H, Schubert S, Zhang D et al. A genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages. Infect Immun 1999 67 (11) 5994-6001
56. Orth D, Grif K, Dierich M P., Würzner R. Variability in tellurite resistance and the ter gene cluster among Shiga toxin-producing Escherichia coli isolated from humans, animals and food. Res Microbiol 2007 158 (2) 105-111
57. Mellmann A, Bielaszewska M, Zimmerhackl L B. et al. Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. Clin Infect Dis 2005 41 (6) 785-792
58. Bielaszewska M, Middendorf B, Köck R et al. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution. Clin Infect Dis 2008 47 (2) 208-217
59. Bielaszewska M, Prager R, Köck R et al. Shiga toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Escherichia coli O26 infection in humans. Appl Environ Microbiol 2007 73 (10) 3144-3150
60. Bielaszewska M, Prager R, Zhang W et al. Chromosomal dynamism in progeny of outbreak-related sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM. Appl Environ Microbiol 2006 72 (3) 1900-1909
61. Mellmann A, Lu S, Karch H et al. Recycling of Shiga toxin 2 genes in sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM. Appl Environ Microbiol 2008 74 (1) 67-72